<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
		<id>http://www.wikiweed.com/index.php?action=history&amp;feed=atom&amp;title=AM-919</id>
		<title>AM-919 - Revision history</title>
		<link rel="self" type="application/atom+xml" href="http://www.wikiweed.com/index.php?action=history&amp;feed=atom&amp;title=AM-919"/>
		<link rel="alternate" type="text/html" href="http://www.wikiweed.com/index.php?title=AM-919&amp;action=history"/>
		<updated>2026-04-07T02:08:17Z</updated>
		<subtitle>Revision history for this page on the wiki</subtitle>
		<generator>MediaWiki 1.24.1</generator>

	<entry>
		<id>http://www.wikiweed.com/index.php?title=AM-919&amp;diff=1473&amp;oldid=prev</id>
		<title>Adm1n: Created page with &quot;AM-919 is an analgesic drug which is a cannabinoid receptor agonist. It is a derivative of HU-210 which has been substituted with a 6β-(3-hydroxypropyl) group. This a...&quot;</title>
		<link rel="alternate" type="text/html" href="http://www.wikiweed.com/index.php?title=AM-919&amp;diff=1473&amp;oldid=prev"/>
				<updated>2015-02-16T15:15:34Z</updated>
		
		<summary type="html">&lt;p&gt;Created page with &amp;quot;AM-919 is an analgesic drug which is a &lt;a href=&quot;/Cannabinoid_receptor&quot; title=&quot;Cannabinoid receptor&quot;&gt;cannabinoid receptor&lt;/a&gt; agonist. It is a derivative of &lt;a href=&quot;/HU-210&quot; title=&quot;HU-210&quot;&gt;HU-210&lt;/a&gt; which has been substituted with a 6β-(3-hydroxypropyl) group. This a...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;AM-919 is an analgesic drug which is a [[cannabinoid receptor]] agonist. It is a derivative of [[HU-210]] which has been substituted with a 6β-(3-hydroxypropyl) group. This adds a &amp;quot;southern&amp;quot; aliphatic hydroxyl group to the molecule as seen in the CP-series of nonclassical cannabinoid drugs, and so AM-919 represents a hybrid structure between the classical and nonclassical [[cannabinoid]] families.&lt;br /&gt;
&lt;br /&gt;
AM-919 is somewhat less potent than HU-210 itself, but is still a potent agonist at both CB1 and CB2 with moderate selectivity for CB1, with a Ki of 2.2nM at CB1 and 3.4nM at CB2.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
&lt;br /&gt;
* [[AM-4030]]&lt;/div&gt;</summary>
		<author><name>Adm1n</name></author>	</entry>

	</feed>